EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Extract Pharmaceuticals, Inc. (the “Company”), for the quarter ended March 31, 2017, as filed with the Securities and Exchange Commission (the “Report”), the undersigned, Peter E. Maddocks, chief executive officer of the Company and chief financial officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

(1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

By: /s/ Peter E. Maddocks 

 Peter E. Maddocks 

 Chief Executive Officer and Chief Financial Officer 

Dated: April 24, 2017